{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:08:11Z","timestamp":1790064491289,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier","isbn-type":[{"value":"9780128126035","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.irn.2017.05.004","type":"book-chapter","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T11:15:14Z","timestamp":1496402114000},"page":"1397-1408","source":"Crossref","is-referenced-by-count":18,"title":["Nonmotor Symptoms in Huntington Disease"],"prefix":"10.1016","author":[{"given":"Francisco","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2017.05.004_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JHD-160206","article-title":"Risk factors for suicidal ideation in people at risk for Huntington's disease","volume":"5","author":"Anderson","year":"2016","journal-title":"Journal of Huntington's Disease"},{"key":"10.1016\/bs.irn.2017.05.004_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.25750","article-title":"Results of the citalopram to enhance cognition in Huntington disease trial","volume":"29","author":"Beglinger","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4088\/JCP.v69n1111","article-title":"Obsessive and compulsive symptoms in prediagnosed Huntington's disease","volume":"69","author":"Beglinger","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.004_bb0020","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/mds.22601","article-title":"Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study","volume":"24","author":"Biglan","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2015.10.001","article-title":"Social cognition in Huntington's disease: A meta-analysis","volume":"297","author":"Bora","year":"2016","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.irn.2017.05.004_bb9000","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1176\/appi.neuropsych.14030051","article-title":"Irritability in a prospective cohort of Huntington's disease mutation carriers","volume":"27","author":"Bouwens","year":"2015","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/bs.irn.2017.05.004_bb0030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ncl.2009.04.001","article-title":"Huntington disease and other choreas","volume":"27","author":"Cardoso","year":"2009","journal-title":"Neurologic Clinics"},{"key":"10.1016\/bs.irn.2017.05.004_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/nmt.13.78","article-title":"Differential diagnosis of Huntington's disease: What the clinician should know","volume":"4","author":"Cardoso","year":"2014","journal-title":"Neurodegenerative Disease Management"},{"key":"10.1016\/bs.irn.2017.05.004_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.0000000000002944","article-title":"Clinical manifestations of intermediate allele carriers in Huntington disease","volume":"87","author":"Cubo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neurol.2016.07.012","article-title":"Guidelines for clinical pharmacological practices in Huntington's disease","volume":"172","author":"D\u00e9sam\u00e9ricq","year":"2016","journal-title":"Revue Neurologique"},{"key":"10.1016\/bs.irn.2017.05.004_bb0050","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/S355","article-title":"A review of cognition in Huntington's disease","volume":"5","author":"Dumas","year":"2013","journal-title":"Frontiers in Bioscience (Scholar Edition)"},{"key":"10.1016\/bs.irn.2017.05.004_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1176\/appi.ajp.2015.14121551","article-title":"Longitudinal psychiatric symptoms in prodromal Huntington's disease: A decade of data","volume":"173","author":"Epping","year":"2016","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.004_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","article-title":"Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk","volume":"29","author":"Fisher","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0070","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5517-4","article-title":"How vital is sleep in Huntington's disease?","volume":"257","author":"Goodman","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0075","article-title":"An international survey-based algorithm for the pharmacologic treatment of irritability in Huntington's disease","volume":"1","author":"Groves","year":"2011","journal-title":"PLoS Currents Huntington Disease, Edition"},{"key":"10.1016\/bs.irn.2017.05.004_bb0080","first-page":"115","article-title":"Study protocol of Registry version 2.0 European Huntington's Disease Network (EHDN)","volume":"46","author":"Handley","year":"2011","journal-title":"Hygeia Public Health"},{"key":"10.1016\/bs.irn.2017.05.004_bb0085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp-2011-301732","article-title":"Cognitive domains that predict time to diagnosis in prodromal Huntington disease","volume":"83","author":"Harrington","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.004_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jad.2013.06.001","article-title":"Suicidal ideation in a European Huntington's disease population","volume":"151","author":"Hubers","year":"2013","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0095","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"The Medical and Surgical Reporter: A Weekly Journal"},{"key":"10.1016\/bs.irn.2017.05.004_bb0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: Reliability and consistency","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamaneurol.2015.2736","article-title":"Clinical-genetic associations in the prospective Huntington at risk observational study (PHAROS): Implications for clinical trials","volume":"73","author":"Huntington Study Group PHAROS Investigators","year":"2016","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.26014","article-title":"Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?","volume":"29","author":"Killoran","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ajmg.b.32332","article-title":"Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype","volume":"168","author":"Krause","year":"2015","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"key":"10.1016\/bs.irn.2017.05.004_bb0120","article-title":"Data analytics from Enroll-HD, a global clinical research platform for Huntington's disease","author":"Landwehrmeyer","year":"2016","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.irn.2017.05.004_bb0125","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","article-title":"Conditions associated with Huntington's disease at death. A case-control study","volume":"45","author":"Lanska","year":"1988","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.24495","article-title":"Sleep deficits but no metabolic deficits in premanifest Huntington's disease","volume":"78","author":"Lazar","year":"2015","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0135","article-title":"Cholinesterase inhibitors for rarer dementias associated with neurological conditions","volume":"3","author":"Li","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2017.05.004_bb0140","article-title":"Is a motor criterion essential for the diagnosis of clinical Huntington disease? Version 2","volume":"5","author":"Loy","year":"2013","journal-title":"PLoS Currents"},{"key":"10.1016\/bs.irn.2017.05.004_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","article-title":"Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease","volume":"25","author":"Martinez-Horta","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5334\/tohm.231","article-title":"The many facets of unawareness in Huntington disease","volume":"4","author":"McCusker","year":"2014","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"10.1016\/bs.irn.2017.05.004_bb0155","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/mds.26675","article-title":"Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations","volume":"31","author":"Mestre","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0160","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mds.25980","article-title":"Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease","volume":"29","author":"Moulton","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mds.25864","article-title":"The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation","volume":"29","author":"Papoutsi","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0170","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis: The PREDICT-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.004_bb0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/jnp.17.4.496","article-title":"Depression and stages of Huntington's disease","volume":"17","author":"Paulsen","year":"2005","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/bs.irn.2017.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26012","article-title":"Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction","volume":"29","author":"Ross","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.05.004_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropsychologia.2010.11.016","article-title":"Visuomotor integration deficits precede clinical onset in Huntington's disease","volume":"49","author":"Say","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.1016\/bs.irn.2017.05.004_bb0190","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.26331","article-title":"Therapeutic advances in Huntington's disease","volume":"30","author":"Shannon","year":"2015","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.05.004_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JHD-140109","article-title":"Unawareness of deficits in Huntington's disease","volume":"2014","author":"Sitek","year":"2014","journal-title":"Journal of Huntington's Disease"},{"key":"10.1016\/bs.irn.2017.05.004_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2017.05.004_bb0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mdc3.12376","article-title":"Huntington's disease: Prevalence and psychological indicators of pain","volume":"4","author":"Underwood","year":"2017","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.irn.2017.05.004_bb0225","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.275","article-title":"Chorea: A journey through history","volume":"5","author":"Vale","year":"2015","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"10.1016\/bs.irn.2017.05.004_bb0230","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: Widespread pathology in Huntington's disease","volume":"8","author":"van der Burgh","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2017.05.004_bb0235","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","article-title":"Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)","volume":"85","author":"van Duijn","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2017.05.004_bb0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington's disease gene carriers","volume":"19","author":"van Duijn","year":"2007","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/bs.irn.2017.05.004_bb0245","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.parkreldis.2008.10.002","article-title":"Daytime somnolence and nocturnal sleep disturbances in Huntington disease","volume":"15","author":"Videnovic","year":"2009","journal-title":"Parkinsonism & Related Disorders"}],"container-title":["International Review of Neurobiology","Nonmotor Parkinson\u2019s: The Hidden Face - Management and the Hidden Face of Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421730048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007477421730048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T14:35:13Z","timestamp":1719239713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007477421730048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128126035"],"references-count":50,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2017.05.004","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}